Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$151.37
al cierre: Oct 28 EDT
$151.40
0.030.02%
Pre-comercialización: 7:36 PM EDT
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
Procter & Gamble Co ha un obiettivo di prezzo di consenso pari a $175.75, stabilito in base alle ultime valutazioni degli analisti di 25. Le ultime 3 valutazioni degli analisti sono state rilasciate da JP Morgan, Raymond James y JP Morgan il octubre 27, 2025, octubre 20, 2025 y octubre 10, 2025. Con un obiettivo di prezzo medio di $167.67 tra le JP Morgan, Raymond James y JP Morgan, c'è un implicito 10.74% upside per Procter & Gamble Co da queste valutazioni degli analisti.
Firmas de analistas que realizan recomendaciones1
JP Morgan
Raymond James
B of A Securities
UBS
Barclays
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para Procter & Gamble
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/27/2025 | 8.98% | JP Morgan | $163 → $165 | Maintains | Neutral | |||
10/20/2025 | 15.59% | Raymond James | $185 → $175 | Maintains | Outperform | |||
10/10/2025 | 7.66% | JP Morgan | $170 → $163 | Maintains | Neutral | |||
10/08/2025 | 14.93% | B of A Securities | $180 → $174 | Maintains | Buy | |||
10/08/2025 | 16.25% | UBS | $180 → $176 | Maintains | Buy | |||
10/01/2025 | 1.06% | Barclays | $164 → $153 | Maintains | Equal-Weight | |||
09/25/2025 | 12.29% | Wells Fargo | $173 → $170 | Maintains | Overweight | |||
08/15/2025 | 16.91% | BNP Paribas | $177 → $177 | Reiterates | Outperform → Outperform | |||
07/31/2025 | 8.32% | Barclays | $161 → $164 | Maintains | Equal-Weight | |||
07/30/2025 | 14.27% | Wells Fargo | $175 → $173 | Maintains | Overweight | |||
07/25/2025 | 12.29% | JP Morgan | $178 → $170 | Downgrade | Overweight → Neutral | |||
07/17/2025 | 18.89% | UBS | $186 → $180 | Maintains | Buy | |||
07/15/2025 | 6.34% | Barclays | $160 → $161 | Maintains | Equal-Weight | |||
07/14/2025 | 12.29% | Evercore ISI Group | $190 → $170 | Downgrade | Outperform → In-Line | |||
06/03/2025 | 25.5% | Evercore ISI Group | $170 → $190 | Maintains | Outperform | |||
05/05/2025 | 8.32% | Piper Sandler | $160 → $164 | Maintains | Neutral | |||
04/25/2025 | 16.91% | RBC Capital | $164 → $177 | Upgrade | Sector Perform → Outperform | |||
04/25/2025 | 18.89% | Truist Securities | $185 → $180 | Maintains | Buy | |||
04/25/2025 | 22.19% | Raymond James | $190 → $185 | Maintains | Outperform | |||
04/25/2025 | 18.89% | Morgan Stanley | $191 → $180 | Maintains | Overweight | |||
04/25/2025 | 19.55% | Citigroup | $200 → $181 | Maintains | Buy | |||
04/25/2025 | 18.89% | B of A Securities | $190 → $180 | Maintains | Buy | |||
04/22/2025 | 8.32% | RBC Capital | $164 → $164 | Reiterates | Sector Perform → Sector Perform | |||
04/11/2025 | 13.61% | JP Morgan | $181 → $172 | Maintains | Overweight | |||
04/03/2025 | 22.19% | Truist Securities | $180 → $185 | Maintains | Buy | |||
03/27/2025 | 8.98% | Barclays | $159 → $165 | Maintains | Equal-Weight | |||
02/24/2025 | 13.61% | Piper Sandler | $173 → $172 | Maintains | Neutral | |||
01/23/2025 | 8.32% | RBC Capital | $164 → $164 | Reiterates | Sector Perform → Sector Perform | |||
01/23/2025 | 8.98% | Stifel | $161 → $165 | Maintains | Hold | |||
01/23/2025 | 18.89% | Wells Fargo | $176 → $180 | Maintains | Overweight | |||
01/23/2025 | 5.02% | Barclays | $155 → $159 | Maintains | Equal-Weight | |||
01/23/2025 | 38.04% | DA Davidson | $209 → $209 | Maintains | Buy | |||
01/22/2025 | 14.27% | Piper Sandler | $174 → $173 | Maintains | Neutral | |||
01/17/2025 | 2.38% | Barclays | $163 → $155 | Maintains | Equal-Weight | |||
01/17/2025 | 6.34% | Stifel | $167 → $161 | Maintains | Hold | |||
01/16/2025 | 24.83% | UBS | $196 → $189 | Maintains | Buy | |||
01/16/2025 | 19.55% | JP Morgan | $186 → $181 | Maintains | Overweight | |||
01/07/2025 | 16.25% | Wells Fargo | $190 → $176 | Maintains | Overweight | |||
12/27/2024 | 38.04% | DA Davidson | $209 → $209 | Maintains | Buy | |||
11/25/2024 | 38.04% | DA Davidson | $160 → $209 | Upgrade | Neutral → Buy | |||
11/22/2024 | 25.5% | Wells Fargo | $188 → $190 | Maintains | Overweight | |||
11/20/2024 | 5.68% | DA Davidson | $160 → $160 | Maintains | Neutral | |||
10/21/2024 | 26.16% | Morgan Stanley | $174 → $191 | Maintains | Overweight | |||
10/21/2024 | 20.87% | Evercore ISI Group | $180 → $183 | Maintains | Outperform | |||
10/21/2024 | 8.32% | RBC Capital | $164 → $164 | Reiterates | Sector Perform → Sector Perform | |||
10/21/2024 | 5.68% | DA Davidson | $159 → $160 | Maintains | Neutral | |||
10/15/2024 | 5.02% | DA Davidson | $159 → $159 | Maintains | Neutral | |||
10/09/2024 | 5.02% | DA Davidson | → $159 | Initiates | → Neutral | |||
09/30/2024 | 7.66% | Barclays | $163 → $163 | Downgrade | Overweight → Equal-Weight | |||
09/24/2024 | 14.93% | Piper Sandler | → $174 | Initiates | → Neutral | |||
09/19/2024 | 22.85% | JP Morgan | $179 → $186 | Maintains | Overweight | |||
08/29/2024 | 25.5% | DZ Bank | → $190 | Upgrade | Hold → Buy | |||
08/01/2024 | 7.66% | Barclays | $174 → $163 | Maintains | Overweight | |||
07/31/2024 | 18.23% | JP Morgan | $181 → $179 | Maintains | Overweight | |||
07/31/2024 | 8.32% | RBC Capital | $157 → $164 | Maintains | Sector Perform | |||
07/24/2024 | 15.59% | Jefferies | $182 → $175 | Downgrade | Buy → Hold | |||
07/23/2024 | 24.83% | TD Cowen | → $189 | Initiates | → Buy | |||
07/22/2024 | 19.55% | JP Morgan | $170 → $181 | Maintains | Overweight | |||
07/22/2024 | 6.34% | Stifel | $157 → $161 | Maintains | Hold | |||
07/19/2024 | 14.93% | Barclays | $170 → $174 | Maintains | Overweight | |||
07/18/2024 | 20.87% | Evercore ISI Group | $177 → $183 | Maintains | Outperform | |||
07/17/2024 | 16.25% | Deutsche Bank | $171 → $176 | Maintains | Buy | |||
07/10/2024 | 25.5% | Citigroup | $177 → $190 | Maintains | Buy | |||
06/24/2024 | 23.51% | Exane BNP Paribas | → $187 | Initiates | → Outperform | |||
04/25/2024 | 22.19% | Argus Research | $180 → $185 | Maintains | Buy | |||
04/23/2024 | 12.29% | Barclays | $168 → $170 | Maintains | Overweight | |||
04/22/2024 | 12.95% | Deutsche Bank | $172 → $171 | Maintains | Buy | |||
04/22/2024 | 20.21% | Jefferies | $175 → $182 | Maintains | Buy | |||
04/12/2024 | 10.96% | Barclays | $165 → $168 | Maintains | Overweight | |||
04/03/2024 | 13.61% | Deutsche Bank | $170 → $172 | Maintains | Buy | |||
03/11/2024 | 15.59% | Truist Securities | $160 → $175 | Upgrade | Hold → Buy | |||
03/01/2024 | 10.96% | Goldman Sachs | → $168 | Reinstates | → Neutral | |||
01/31/2024 | 5.68% | Truist Securities | $155 → $160 | Maintains | Hold | |||
01/25/2024 | 8.98% | Barclays | $160 → $165 | Maintains | Overweight | |||
01/24/2024 | 3.7% | RBC Capital | $156 → $157 | Maintains | Sector Perform | |||
01/24/2024 | 3.7% | Stifel | $155 → $157 | Maintains | Hold | |||
01/24/2024 | 17.57% | UBS | $172 → $178 | Maintains | Buy | |||
01/24/2024 | 12.29% | Wells Fargo | $162 → $170 | Maintains | Overweight | |||
01/24/2024 | 15.59% | Raymond James | $170 → $175 | Maintains | Outperform | |||
01/18/2024 | 7% | JP Morgan | $169 → $162 | Maintains | Overweight | |||
01/16/2024 | 5.68% | Barclays | $164 → $160 | Maintains | Overweight | |||
11/13/2023 | 16.91% | Jefferies | → $177 | Initiates | → Buy | |||
10/20/2023 | 2.38% | DZ Bank | → $155 | Upgrade | Sell → Hold | |||
10/19/2023 | 7% | Wells Fargo | $160 → $162 | Maintains | Overweight | |||
10/19/2023 | 2.38% | Stifel | $151 → $155 | Maintains | Hold | |||
10/16/2023 | -0.26% | Stifel | $161 → $151 | Maintains | Hold | |||
10/12/2023 | 1.72% | Barclays | $166 → $154 | Maintains | Overweight | |||
10/12/2023 | 11.62% | JP Morgan | $172 → $169 | Maintains | Overweight | |||
10/12/2023 | 1.06% | Bernstein | $162 → $153 | Maintains | Market Perform | |||
09/22/2023 | 18.23% | HSBC | → $179 | Initiates | → Buy | |||
09/08/2023 | — | William Blair | — | Initiates | → Market Perform | |||
08/01/2023 | 14.93% | Morgan Stanley | $174 → $174 | Reiterates | Overweight → Overweight | |||
08/01/2023 | 15.59% | B of A Securities | $170 → $175 | Maintains | Buy | |||
08/01/2023 | 9.64% | Barclays | $160 → $166 | Maintains | Overweight | |||
07/31/2023 | 10.3% | RBC Capital | $165 → $167 | Maintains | Sector Perform | |||
07/31/2023 | 12.29% | Wells Fargo | $165 → $170 | Maintains | Overweight | |||
07/31/2023 | 14.27% | Deutsche Bank | $170 → $173 | Maintains | Buy | |||
07/25/2023 | 14.93% | Morgan Stanley | $174 → $174 | Reiterates | Overweight → Overweight | |||
07/20/2023 | 5.68% | Barclays | $167 → $160 | Maintains | Overweight | |||
07/11/2023 | 16.91% | Citigroup | → $177 | Reiterates | Buy → Buy |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de Procter & Gamble (PG)?
El último precio objetivo de Procter & Gamble (NYSE:PG) fue comunicado por JP Morgan el octubre 27, 2025. La firma de analistas fijó un precio objetivo para $165.00 que espera PG a rise dentro de 12 meses (un posible 8.98% upside). 42 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre Procter & Gamble (PG)?
La última calificación de analistas para Procter & Gamble (NYSE:PG) fue proporcionada por JP Morgan, y Procter & Gamble mantuvo su neutral calificación.
¿Cuándo se produjo la última revisión al alza de Procter & Gamble (PG)?
La última revisión al alza de Procter & Gamble Co se produjo en abril 25, 2025, cuando RBC Capital elevó su precio objetivo a $177. RBC Capital anteriormente tenía a sector perform para Procter & Gamble Co.
¿Cuándo fue la última revisión a la baja de Procter & Gamble (PG)?
La última revisión a la baja de Procter & Gamble Co se produjo en julio 25, 2025, cuando JP Morgan cambió su precio objetivo de $178 a $170 para Procter & Gamble Co.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para Procter & Gamble (PG)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Procter & Gamble, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Procter & Gamble se registró el octubre 27, 2025, por lo que la próxima calificación estará disponible en torno al octubre 27, 2026.
¿Es correcta la calificación de los analistas sobre Procter & Gamble (PG)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Procter & Gamble (PG) fue un mantuvo con un precio objetivo de $163.00 a $165.00. El precio actual al que cotiza Procter & Gamble (PG) es de $151.40, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.